Lifshitz Law PLLC Announces Investigations of Eagle Pharmaceuticals, Inc. (NASDAQ:EGRX), ON Semiconductor Corporation (NASDAQ: ON), Mercury Systems, Inc. (NASDAQ: MRCY)
Eagle Pharmaceuticals, Inc. (NASDAQ:EGRX) is under investigation by Lifshitz Law PLLC for possible securities laws violations and/or breaches of fiduciary duties. Allegations include slower-than-anticipated pull-through from a wholesale customer, overstated revenue, ineffective internal controls, and misleading positive statements.
Negative
Allegations of slower-than-anticipated pull-through from a wholesale customer
Overstated revenue
Ineffective internal controls
Misleading positive statements
12/15/2023 - 07:37 PM
NEW YORK, December 15, 2023 / ACCESSWIRE / Lifshitz Law PLLC:
Eagle Pharmaceuticals, Inc. (NASDAQ:EGRX)
Lifshitz Law PLLC announces investigation into possible securities laws violations and/or breaches of fiduciary duties in connection with allegations that the Company failed to disclose to investors: (i) that the Company was experiencing slower-than-anticipated pull-though from a wholesale customer predominantly due to expiry of inventory; (ii) that, as a result, the Company had overstated its revenue; (iii) that the Company did not have effective internal controls and procedures over financial reporting as to PEMFEXY sales; and (iv) as a result of the foregoing, the Company's positive statements about its business, operations, and prospects were materially misleading and/or lacked a reasonable basis.
If you are an EGRX investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at info@lifshitzlaw.com .
ON Semiconductor Corporation (NASDAQ:ON)
Lifshitz Law PLLC announces investigation into possible securities laws violations and/or breaches of fiduciary duties in connection with allegations that misrepresented to investors: (i) the demand for the Company's silicon carbide ("SiC") and other products, and (ii) the sustainability of the Company's revenue growth, by overstating the impact of the Company's long-term supply agreements ("LTSAs") on the achievability of its revenue streams. During the Relevant Period, the Company's market capitalization value reached a high of $46.6 billion on August 1, 2023, before falling to $28.2 billion on October 30, 2023.
If you are an ON investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at info@lifshitzlaw.com .
Mercury Systems, Inc. (NASDAQ:MRCY)
Lifshitz Law PLLC announces investigation into possible securities laws violations and/or breaches of fiduciary duties in connection with allegations that Mercury was a serial acquirer that used acquisitions and improper revenue recognition practices to mask its inability to grow organically. Further, the Company repeatedly misled investors to believe that its growth was organic by misrepresenting several elements of Mercury's business, including by hiding that Mercury had switched from "point-in-time" to "long-term contracts" in order to improperly boost reported revenues and that several of Mercury's projects were in significant distress, including projects related to Mercury's acquisition of Physical Optics Corporation. The Company also lied to investors about its strategic growth initiative, 1MPACT, which was designed to improve profit margins but unbeknownst to investors was used to disguise regular expenses as restructuring costs, enabling Mercury to claim that recurring expenses were one-time costs.
If you are a MRCY investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at info@lifshitzlaw.com .
Contact:
Joshua M. Lifshitz, Esq.jlifshitz@lifshitzlaw.com
SOURCE: Lifshitz Law PLLC
press release on accesswire.com
What is the ticker symbol for Eagle Pharmaceuticals, Inc.?
The ticker symbol for Eagle Pharmaceuticals, Inc. is EGRX.
What are the allegations against Eagle Pharmaceuticals, Inc.?
The allegations include slower-than-anticipated pull-through from a wholesale customer, overstated revenue, ineffective internal controls, and misleading positive statements.
What is Lifshitz Law PLLC investigating regarding Eagle Pharmaceuticals, Inc.?
Lifshitz Law PLLC is investigating possible securities laws violations and/or breaches of fiduciary duties.
What are the potential consequences of the allegations for Eagle Pharmaceuticals, Inc.?
The potential consequences may include legal repercussions, financial penalties, and damage to the company's reputation and stock performance.
